| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 16 |
| 1 | METHOTREXATE | 15 |
| 2 | TACROLIMUS | 15 |
| 3 | ADALIMUMAB | 14 |
| 4 | ADALIMUMAB-AATY | 14 |
| 5 | ADALIMUMAB-ADAZ | 14 |
| 6 | ADALIMUMAB-FKJP | 14 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 14 |
| 8 | TACROLIMUS OINTMENT 0.1% | 14 |
| 9 | HYDROXYCHLOROQUINE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PIRTOBRUTINIB | 2 | 0.0020 |
| 1 | BACILLUS CALMETTE-GUERIN | 2 | 0.0011 |
| 2 | GLOFITAMAB | 2 | 0.0007 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 5 | 0.0006 |
| 4 | ADALIMUMAB-FKJP | 14 | 0.0003 |
| 5 | HUMAN IMMUNOGLOBULIN G | 6 | 0.0003 |
| 6 | ADALIMUMAB-AATY | 14 | 0.0003 |
| 7 | MYCOPHENILIC ACID | 6 | 0.0003 |
| 8 | ADALIMUMAB-ADAZ | 14 | 0.0003 |
| 9 | MYCOPHENOLIC ACID | 6 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 2 | 0.0011 |
| 1 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 2 | 0.0005 |
| 2 | Human Immunoglobulin G [EPC] | 6 | 0.0003 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 6 | 0.0003 |
| 4 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 5 | Penem Antibacterial [EPC] | 3 | 0.0001 |
| 6 | Glycopeptide Antibacterial [EPC] | 5 | 0.0001 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 10 | 0.0001 |
| 8 | Oxazolidinone Antibacterial [EPC] | 2 | 0.0001 |
| 9 | Purine Antimetabolite [EPC] | 6 | 0.0001 |